BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3306268)

  • 1. Systemic reactions to ophthalmic drug preparations.
    Fraunfelder FT; Meyer SM
    Med Toxicol Adverse Drug Exp; 1987; 2(4):287-93. PubMed ID: 3306268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular toxicology update.
    Fraunfelder FT; Meyer SM
    Aust J Ophthalmol; 1984 Nov; 12(4):391-4. PubMed ID: 6397176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How safe are ocular drugs in pediatrics?
    Palmer EA
    Ophthalmology; 1986 Aug; 93(8):1038-40. PubMed ID: 3763151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse reactions to topical ocular autonomic agents.
    Norden LC
    J Am Optom Assoc; 1978 Jan; 49(1):75-80. PubMed ID: 146723
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic side effects associated with the ophthalmic administration of timolol.
    Munroe WP; Rindone JP; Kershner RM
    Drug Intell Clin Pharm; 1985 Feb; 19(2):85-9. PubMed ID: 3882377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic toxicity of cyclopentolate hydrochloride in adults following topical ocular instillation.
    Awan KJ
    Ann Ophthalmol; 1976 Jul; 8(7):803-6. PubMed ID: 962257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3. Phenylephrine hydrochloride.
    Meyer SM; Fraunfelder FT
    Ophthalmology; 1980 Nov; 87(11):1177-80. PubMed ID: 7243210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac safety of ophthalmic timolol.
    Mäenpää J; Pelkonen O
    Expert Opin Drug Saf; 2016 Nov; 15(11):1549-1561. PubMed ID: 27534869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: systemic absorption of topically applied ocular drugs in humans.
    Salminen L
    J Ocul Pharmacol; 1990; 6(3):243-9. PubMed ID: 2290070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grand mal seizure in a child 30 minutes after Cyclogyl (cyclopentolate hydrochloride) and 10% Neo-Synephrine (phenylephrine hydrochloride) eye drops were instilled.
    Demayo AP; Reidenberg MM
    Pediatrics; 2004 May; 113(5):e499-500. PubMed ID: 15121994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker.
    Shore JH; Fraunfelder FT; Meyer SM
    J Clin Psychopharmacol; 1987 Aug; 7(4):264-7. PubMed ID: 3624510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal necrotising enterocolitis due to mydriatic eye drops.
    Ozgun U; Demet T; Ozge KA; Zafer D; Murat S; Mehmet Y; Nilgun K
    J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S147-9. PubMed ID: 24906272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.
    Järvinen K; Urtti A
    J Ocul Pharmacol; 1992; 8(2):91-8. PubMed ID: 1506759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic effects of eye drops.
    Davidson SI
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):487-95. PubMed ID: 4143267
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic effects of eye drops.
    Adler AG; McElwain GE; Merli GJ; Martin JH
    Arch Intern Med; 1982 Dec; 142(13):2293-4. PubMed ID: 7149872
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants.
    Elibol O; Alçelik T; Yüksel N; Caglar Y
    Acta Ophthalmol Scand; 1997 Apr; 75(2):178-80. PubMed ID: 9197568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic reactions to topical therapy.
    Ellis PP
    Int Ophthalmol Clin; 1971; 11(2):1-11. PubMed ID: 4948452
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe bronchial spasm crises induced by topical administration of eyedrops with timolol base, a non-selective beta blocking agent].
    Confalonieri M; Aiolfi S; Patrini G; Scartabellati A; Ghio L; Mauri F; Della Porta R; Gandola L
    Recenti Prog Med; 1991; 82(7-8):402-4. PubMed ID: 1947406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse systemic effects from pledgets of topical ocular phenylephrine 10%.
    Fraunfelder FW; Fraunfelder FT; Jensvold B
    Am J Ophthalmol; 2002 Oct; 134(4):624-5. PubMed ID: 12383833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
    Schuman JS
    Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.